"The US Food and Drug Administration (FDA) has approved a fixed-dose combination of memantine hydrochloride extended-release (XR) and donepezil hydrochloride (Namzaric, Actavis plc/Adamas Pharm) for moderate to severe Alzheimer's-related de"...
- Instruct patients to inform their physician or healthcare provider if they are pregnant or breastfeeding.
- Inform patients who are breastfeeding to use alternate infant nutrition sources (e.g. stored breast milk or infant formula) for 24 hours ( > 10 half-lives of radioactive decay for the F 18 isotope) after administration of the drug or to avoid use of the drug.
Last reviewed on RxList: 9/9/2016
This monograph has been modified to include the generic and brand name in many instances.
Additional Neuraceq Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.